Literature DB >> 6080171

Amphotericin B therapy in the treatment of presumed Histoplasma chorioretinitis: a further appraisal.

C L Giles, H F Falls.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6080171      PMCID: PMC1310264     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


× No keyword cloud information.
  8 in total

Review 1.  AMPHOTERICIN B TOXICITY; REVIEW OF SELECTED ASPECTS OF PHARMACOLOGY.

Authors:  J E BENNETT
Journal:  Ann Intern Med       Date:  1964-08       Impact factor: 25.391

2.  SPECIFIC OCULAR UVEAL LESIONS IN PATIENTS WITH EVIDENCE OF HISTOPLASMOSIS.

Authors:  T E VAN METRE; A E MAUMENEE
Journal:  Arch Ophthalmol       Date:  1964-03

3.  OCULAR HISTOPLASMOSIS.

Authors:  G J JARVIS; C MCCULLOCH
Journal:  Can Med Assoc J       Date:  1963-12-21       Impact factor: 8.262

4.  Serologic effects of histoplasmin skin testing.

Authors:  W M NICHOLAS; J A WIER; L R KUHN; C C CAMPBELL; L B NOLTE; G B HILL
Journal:  Am Rev Respir Dis       Date:  1961-02

5.  The Probable Role of Benign Histoplasmosis in the Etiology of Granulomatous Uveitis.

Authors:  A C Woods; H E Wahlen
Journal:  Trans Am Ophthalmol Soc       Date:  1959

6.  Histoplasma capsulatum in a human eye.

Authors:  K L Hoefnagels; P M Pijpers
Journal:  Am J Ophthalmol       Date:  1967-04       Impact factor: 5.258

7.  Pharmacology, toxicity, and therapeutic usefulness of amphotericin B.

Authors:  W T Butler
Journal:  JAMA       Date:  1966-01-31       Impact factor: 56.272

8.  Absence of so-called histoplasma uveitis in 134 cases of proven histoplasmosis.

Authors:  G L Spaeth
Journal:  Arch Ophthalmol       Date:  1967-01
  8 in total
  1 in total

Review 1.  Natural history and reactivation studies of experimental ocular histoplasmosis in a primate model.

Authors:  R E Smith
Journal:  Trans Am Ophthalmol Soc       Date:  1982
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.